Extracellular Matrix- and Integrin Adhesion Complexes-Related Genes in the Prognosis of Prostate Cancer Patients’ Progression-Free Survival

Prostate cancer is a heterogeneous disease, and one of the main obstacles in its management is the inability to foresee its course. Therefore, novel biomarkers are needed that will guide the treatment options. The extracellular matrix (ECM) is an important part of the tumor microenvironment that largely influences cell behavior. ECM components are ligands for integrin receptors which are involved in every step of tumor progression. An underlying characteristic of integrin activation and ligation is the formation of integrin adhesion complexes (IACs), intracellular structures that carry information conveyed by integrins. By using The Cancer Genome Atlas data, we show that the expression of ECM- and IACs-related genes is changed in prostate cancer. Moreover, machine learning methods revealed that they are a source of biomarkers for progression-free survival of patients that are stratified according to the Gleason score. Namely, low expression of FMOD and high expression of PTPN2 genes are associated with worse survival of patients with a Gleason score lower than 9. The FMOD gene encodes protein that may play a role in the assembly of the ECM and the PTPN2 gene product is a protein tyrosine phosphatase activated by integrins. Our results suggest potential biomarkers of prostate cancer progression.

[1]  P. Konjevoda,et al.  Prognostic Significance of Amino Acid Metabolism-Related Genes in Prostate Cancer Retrieved by Machine Learning , 2023, Cancers.

[2]  François Bordeleau,et al.  The Extracellular Matrix Stiffening: A Trigger of Prostate Cancer Progression and Castration Resistance? , 2022, Cancers.

[3]  T. Tilli,et al.  Fibromodulin Gene Variants (FMOD) as Potential Biomarkers for Prostate Cancer and Benign Prostatic Hyperplasia , 2022, Disease markers.

[4]  I. Weber,et al.  Adhesion of Dictyostelium Amoebae to Surfaces: A Brief History of Attachments , 2022, Frontiers in Cell and Developmental Biology.

[5]  Yingyi Wang,et al.  Extracellular Matrix-Based Gene Expression Signature Defines Two Prognostic Subtypes of Hepatocellular Carcinoma With Different Immune Microenvironment Characteristics , 2022, Frontiers in Molecular Biosciences.

[6]  E. Danen,et al.  Targeting Integrins for Cancer Therapy - Disappointments and Opportunities , 2022, Frontiers in Cell and Developmental Biology.

[7]  Lei Li,et al.  Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients , 2022, BMC Cancer.

[8]  Jiayu Ding,et al.  PTPN2, A Key Predictor of Prognosis for Pancreatic Adenocarcinoma, Significantly Regulates Cell Cycles, Apoptosis, and Metastasis , 2022, Frontiers in Immunology.

[9]  D. Lambrechts,et al.  Antizyme Inhibitor 1 regulates matrikine expression and enhances the metastatic potential of aggressive primary prostate cancer. , 2022, Molecular cancer research : MCR.

[10]  Yi-Yun Chen,et al.  The catalytic activity of TCPTP is auto-regulated by its intrinsically disordered tail and activated by Integrin alpha-1 , 2022, Nature communications.

[11]  M. Jücker,et al.  The Functional Role of Extracellular Matrix Proteins in Cancer , 2022, Cancers.

[12]  M. Humphries,et al.  The Tongue Squamous Carcinoma Cell Line Cal27 Primarily Employs Integrin α6β4-Containing Type II Hemidesmosomes for Adhesion Which Contribute to Anticancer Drug Sensitivity , 2021, Frontiers in Cell and Developmental Biology.

[13]  A. Houtsmuller,et al.  A Layered View on Focal Adhesions , 2021, Biology.

[14]  W. Guan,et al.  Extracellular Matrix Characterization in Gastric Cancer Helps to Predict Prognosis and Chemotherapy Response , 2021, Frontiers in Oncology.

[15]  S. Macdonald,et al.  Emerging therapeutic opportunities for integrin inhibitors , 2021, Nature reviews. Drug discovery.

[16]  Z. Jie,et al.  Identification of a Tumor Microenvironment-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Colon Cancer , 2021, Oxidative medicine and cellular longevity.

[17]  J. Ivaska,et al.  Integrin adhesion complexes , 2021, Current Biology.

[18]  P. Liu.  Overexpression and Prognostic Significance of PTPN2 Maybe A Novel Immunotherapy Target in Renal Clear Cell Carcinoma , 2021 .

[19]  Lin Zhou,et al.  Extracellular matrix and its therapeutic potential for cancer treatment , 2021, Signal Transduction and Targeted Therapy.

[20]  A. Rojiani,et al.  Prognostic and therapeutic implications of extracellular matrix associated gene signature in renal clear cell carcinoma , 2021, Scientific Reports.

[21]  Lilong Liu,et al.  Integrative Analysis of Methylation and Copy Number Variations of Prostate Adenocarcinoma Based on Weighted Gene Co-expression Network Analysis , 2021, Frontiers in Oncology.

[22]  Xiao-bin Cui,et al.  An Extracellular Matrix-Based Signature Associated With Immune Microenvironment Predicts the Prognosis and Therapeutic Responses of Patients With Oesophageal Squamous Cell Carcinoma , 2021, Frontiers in Molecular Biosciences.

[23]  Hayley J. Sharpe,et al.  Protein tyrosine phosphatases in cell adhesion , 2021, The Biochemical journal.

[24]  Allison P. Heath,et al.  The NCI Genomic Data Commons , 2021, Nature Genetics.

[25]  S. Ricard-Blum,et al.  A guide to the composition and functions of the extracellular matrix , 2021, The FEBS journal.

[26]  T. Cox.  The matrix in cancer , 2021, Nature Reviews Cancer.

[27]  T. H. van der Kwast,et al.  Prostate cancer , 2021, Nature Reviews Disease Primers.

[28]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[29]  Ivana Samaržija.  Post-Translational Modifications That Drive Prostate Cancer Progression , 2021, Biomolecules.

[30]  Li Yang,et al.  PTPN2 Expression in Cystadenocarcinoma Ovary and It’s Clinical Value Based on TCGA Database , 2021 .

[31]  M. Humphries,et al.  KANK family proteins in cancer. , 2020, The international journal of biochemistry & cell biology.

[32]  H. G. van der Poel,et al.  EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. , 2020, European urology.

[33]  Z. Werb,et al.  Concepts of extracellular matrix remodelling in tumour progression and metastasis , 2020, Nature Communications.

[34]  M. Karsdal,et al.  Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma , 2020, Journal for ImmunoTherapy of Cancer.

[35]  A. Radenović,et al.  Recent Advances and Prospects in the Research of Nascent Adhesions , 2020, Frontiers in Physiology.

[36]  G. Aralica,et al.  Prognostic Significance of Lacunarity in Preoperative Biopsy of Colorectal Cancer , 2020, Pathology & Oncology Research.

[37]  M. Humphries,et al.  Integrin Crosstalk Contributes to the Complexity of Signalling and Unpredictable Cancer Cell Fates , 2020, Cancers.

[38]  H. G. van der Poel,et al.  Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations. , 2020, European urology focus.

[39]  M. Humphries,et al.  KANK2 Links αVβ5 Focal Adhesions to Microtubules and Regulates Sensitivity to Microtubule Poisons and Cell Migration , 2020, Frontiers in Cell and Developmental Biology.

[40]  V. Koyyala,et al.  The tumor microenvironment , 2020, Current Biology.

[41]  A. Haese*,et al.  High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer , 2019, BMC Cancer.

[42]  M. Gleave,et al.  Towards precision oncology in advanced prostate cancer , 2019, Nature Reviews Urology.

[43]  M. Bachmann,et al.  Cell Adhesion by Integrins. , 2019, Physiological reviews.

[44]  Hellyeh Hamidi,et al.  Mechano-responsiveness of fibrillar adhesions on stiffness-gradient gels , 2019, bioRxiv.

[45]  U. Testa,et al.  Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications , 2019, Medicines.

[46]  R. Stupp,et al.  Are Integrins Still Practicable Targets for Anti-Cancer Therapy? , 2019, Cancers.

[47]  Reza Salarinia,et al.  The role of fibromodulin in cancer pathogenesis: implications for diagnosis and therapy , 2019, Cancer Cell International.

[48]  Pere Roca-Cusachs,et al.  Integrins as biomechanical sensors of the microenvironment , 2019, Nature Reviews Molecular Cell Biology.

[49]  T. Hortobágyi,et al.  Extracellular matrix differences in glioblastoma patients with different prognoses , 2018, Oncology letters.

[50]  M. Lakadamyali,et al.  Reticular adhesions are a distinct class of cell-matrix adhesions that mediate attachment during mitosis , 2018, Nature Cell Biology.

[51]  Hellyeh Hamidi,et al.  Every step of the way: integrins in cancer progression and metastasis , 2018, Nature Reviews Cancer.

[52]  J. Schneider,et al.  The β3‐integrin endothelial adhesome regulates microtubule‐dependent cell migration , 2018, EMBO reports.

[53]  Chwee Teck Lim,et al.  An extracellular matrix-related prognostic and predictive indicator for early-stage non-small cell lung cancer , 2017, Nature Communications.

[54]  S. Goodman,et al.  Integrins as Therapeutic Targets: Successes and Cancers , 2017, Cancers.

[55]  P. Koistinen,et al.  An extracellular matrix signature in leukemia precursor cells and acute myeloid leukemia , 2017, Haematologica.

[56]  Mark S. Litwin,et al.  The Diagnosis and Treatment of Prostate Cancer: A Review , 2017, JAMA.

[57]  Gianluca Bontempi,et al.  TCGA Workflow: Analyze cancer genomics and epigenomics data using Bioconductor packages , 2016, F1000Research.

[58]  L. Lessard,et al.  PTP1B Deficiency Enables the Ability of a High-Fat Diet to Drive the Invasive Character of PTEN-Deficient Prostate Cancers. , 2016, Cancer research.

[59]  N. Reyes,et al.  Gene Expression Profiling of Prostate Cancer–Associated Genes Identifies Fibromodulin as Potential Novel Biomarker for Prostate Cancer , 2016, The International journal of biological markers.

[60]  Gianluca Bontempi,et al.  TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data , 2015, Nucleic acids research.

[61]  F. Nakamura,et al.  PTP1B triggers integrin-mediated repression of myosin activity and modulates cell contractility , 2015, Biology Open.

[62]  S. Çalışkan,et al.  Clinical significance of single microscopic focus of adenocarcinoma at prostate biopsy , 2015, Prostate international.

[63]  Adam Byron,et al.  Definition of a consensus integrin adhesome and its dynamics during adhesion complex assembly and disassembly , 2015, Nature Cell Biology.

[64]  Philip Rowe,et al.  Essential Statistics for the Pharmaceutical Sciences: Rowe/Essential Statistics for the Pharmaceutical Sciences , 2015 .

[65]  B. Ripley,et al.  Recursive Partitioning and Regression Trees , 2015 .

[66]  S. Carr,et al.  The extracellular matrix: Tools and insights for the "omics" era. , 2015, Matrix biology : journal of the International Society for Matrix Biology.

[67]  G. Walko,et al.  Molecular architecture and function of the hemidesmosome , 2014, Cell and Tissue Research.

[68]  B. Geiger,et al.  The integrin adhesome: from genes and proteins to human disease , 2014, Nature Reviews Molecular Cell Biology.

[69]  C. Arregui,et al.  Protein tyrosine phosphatase PTP1B in cell adhesion and migration , 2013, Cell adhesion & migration.

[70]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[71]  C. Arregui,et al.  PTP1B promotes focal complex maturation, lamellar persistence and directional migration , 2013, Journal of Cell Science.

[72]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[73]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[74]  J. Gratton,et al.  The Phosphatase PTP-PEST/PTPN12 Regulates Endothelial Cell Migration and Adhesion, but Not Permeability, and Controls Vascular Development and Embryonic Viability* , 2012, The Journal of Biological Chemistry.

[75]  Donna P. Ankerst,et al.  Handbook of statistics in clinical oncology , 2012 .

[76]  L. Lessard,et al.  PTP1B is an androgen receptor-regulated phosphatase that promotes the progression of prostate cancer. , 2012, Cancer research.

[77]  M. Parsons,et al.  Spatial and temporal regulation of integrin signalling during cell migration. , 2011, Current opinion in cell biology.

[78]  M. Schwartz.  Integrins and extracellular matrix in mechanotransduction. , 2010, Cold Spring Harbor perspectives in biology.

[79]  Bernd Hoffmann,et al.  Filopodial focal complexes direct adhesion and force generation towards filopodia outgrowth , 2010, Cell adhesion & migration.

[80]  J. Ivaska,et al.  The protein tyrosine phosphatase TCPTP controls VEGFR2 signalling , 2008, Journal of Cell Science.

[81]  T. Sørlie,et al.  Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome , 2008, The Journal of pathology.

[82]  S. Itzkovitz,et al.  Functional atlas of the integrin adhesome , 2007, Nature Cell Biology.

[83]  S. Sahu,et al.  Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells. , 2007, American journal of physiology. Cell physiology.

[84]  M. Osmak,et al.  Integrin-Mediated Drug Resistance , 2006 .

[85]  P. di Sant'Agnese,et al.  Protein tyrosine phosphatase PTP1B is involved in neuroendocrine differentiation of prostate cancer , 2006, The Prostate.

[86]  K. Ulm,et al.  Statistical Methods to Identify Predictive Factors , 2005 .

[87]  D. Machin,et al.  Prognostic Factor Studies , 2005 .

[88]  John Fox,et al.  GETTING STARTED WITH THE R COMMANDER: A BASIC-STATISTICS GRAPHICAL USER INTERFACE TO R , 2005 .

[89]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[90]  F. Liu,et al.  Protein tyrosine phosphatase 1B negatively regulates integrin signaling , 1998, Current Biology.

[91]  R. Pulido,et al.  The role of protein tyrosine phosphatases in prostate cancer biology. , 2019, Biochimica et biophysica acta. Molecular cell research.

[92]  N. Reyes,et al.  The small leucine rich proteoglycan fibromodulin is overexpressed in human prostate epithelial cancer cell lines in culture and human prostate cancer tissue. , 2016, Cancer biomarkers : section A of Disease markers.

[93]  T. Therneau,et al.  An Introduction to Recursive Partitioning Using the RPART Routines , 2015 .

[94]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[95]  Alexandra Naba,et al.  Overview of the matrisome--an inventory of extracellular matrix constituents and functions. , 2012, Cold Spring Harbor perspectives in biology.

[96]  T. Pellinen,et al.  Negative regulation of EGFR signalling through integrin-α1β1-mediated activation of protein tyrosine phosphatase TCPTP , 2005, Nature Cell Biology.